A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19

A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19

Background: The outbreak of a new coronavirus (SARS-CoV-2) poses a great challenge to global public health. New and effective intervention strategies are urgently needed to combat the disease. Methods: We conducted an open-label, non-randomized, clinical trial involving moderate COVID-19 patients ac...

Full description

Bibliographic Details
Main Authors: Weihui Fu, Yan Liu, Lu Xia, Min Li, Zhigang Song, Huiliang Hu, Zongguo Yang, Lin Wang, Xiaobo Cheng, Mei Wang, Rongrong Jiang, Li Liu, Xiaoting Mao, Jun Chen, Yun Ling, Lin Zhang, Jin Yan, Fei Shan, Corklin Steinhart, Xiaoyan Zhang, Tongyu Zhu, Jianqing Xu, Hongzhou Lu
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:EClinicalMedicine
Subjects:
COVID-19
SARS-CoV-2
TFF2
IFN-κ
Aerosol inhalation
Clinical trial
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020302224

Similar Items

Similar Items